Calliditas Therapeutics AB (publ) Operating Cash Flow | CALT

Annual Operating Cash Flow Calliditas Therapeutics AB (publ)

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-435 M	-311 M	-462 M	-309 M	-71 M	-128 M	-	-	-	-	-	-	-

All numbers in SEK currency

Indicator range from annual reports

Maximum	Minimum	Average
-71 M	-462 M	-286 M

Quarterly Operating Cash Flow Calliditas Therapeutics AB (publ)

2024-Q2	2023-Q4	2023-Q2	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-7.04 M	-435 M	-163 M	-311 M	-	-	-191 M	-462 M	-	-133 M	-134 M	-309 M	-	-67 M	-	-71 M	-	-	-	-128 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in SEK currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-7.04 M	-462 M	-201 M

Operating Cash Flow of other stocks in the Drug manufacturers industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
OrganiGram Holdings OGI	3.87 M	$ 0.94	0.18 %	$ 89.6 M	Canada
Organogenesis Holdings ORGO	-10.3 M	$ 1.29	2.19 %	$ 163 M	USA
Pacira BioSciences PCRX	152 M	$ 25.05	0.42 %	$ 1.12 B	USA
Perrigo Company plc PRGO	238 M	$ 14.44	1.3 %	$ 2 B	USA
Relmada Therapeutics RLMD	-45.8 M	$ 3.48	0.68 %	$ 137 M	USA
Rockwell Medical RMTI	-659 K	$ 8.23	0.93 %	$ 296 M	USA
SCYNEXIS SCYX	-5.28 M	$ 5.03	1.07 %	$ 251 M	USA
Solid Biosciences SLDB	-156 M	$ 7.06	3.07 %	$ 618 M	USA
Sundial Growers SNDL	70.9 M	$ 1.25	0.81 %	$ 323 M	Canada
Sonoma Pharmaceuticals SNOA	-3.93 M	$ 1.22	0.81 %	$ 2.05 M	USA
Tilray TLRY	-94.6 M	$ 3.72	3.05 %	$ 3.31 B	Canada
TherapeuticsMD TXMD	-159 M	$ 2.01	1.46 %	$ 23.3 M	USA
Veru VERU	-30 M	$ 2.55	1.59 %	$ 37.3 M	USA
Viatris VTRS	2.32 B	$ 17.62	0.11 %	$ 20.2 B	USA
cbdMD YCBD	-1.45 M	$ 0.43	0.29 %	$ 1.73 M	USA
OptiNose OPTN	-44.7 M	-	-	$ 1.08 B	USA
PetIQ PETQ	61.9 M	-	1.64 %	$ 400 M	USA
Endo International plc ENDP	435 M	-	-	$ 28.9 M	Irlanda
Radius Health RDUS	-22.4 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	-1 M	-	-4.76 %	$ 65.3 M	USA
Adamis Pharmaceuticals Corporation ADMP	-25.9 M	-	0.86 %	$ 117 M	USA
Agile Therapeutics AGRX	-9.58 M	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	-14.3 M	-	-	$ 142 M	USA
PLx Pharma PLXP	-32.1 M	-	-27.8 %	$ 2.56 M	USA
Athenex ATNX	-131 M	-	-23.39 %	$ 1.76 M	USA
Aerie Pharmaceuticals AERI	-99.2 M	-	-	$ 754 M	USA
Tricida TCDA	-140 M	-	-	$ 3.25 M	USA
Zynerba Pharmaceuticals ZYNE	-23 M	-	-	$ 55.5 M	USA
Avadel Pharmaceuticals plc AVDL	-46.9 M	-	-	$ 2.06 B	France
Evoke Pharma EVOK	-5.46 M	-	-	$ 36.6 M	USA
Lannett Company LCI	-7.12 M	-	1.15 %	$ 7.11 M	USA
Catalent CTLT	268 M	-	-	$ 11.5 B	USA
DURECT Corporation DRRX	-19.1 M	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	50.7 M	-	-39.89 %	$ 27.7 M	USA
HEXO Corp. HEXO	-117 M	-	2.45 %	$ 38.1 M	Canada
AcelRx Pharmaceuticals ACRX	-11.4 M	-	7.5 %	$ 6.35 M	USA
Assertio Holdings ASRT	-28.2 M	-	-	$ 150 M	USA
Jupiter Wellness JUPW	-6.4 M	-	-	$ 33.6 M	USA
Neoleukin Therapeutics NLTX	-77.2 M	-	-	$ 193 M	Canada
ProPhase Labs PRPH	-8.34 M	-	-	$ 5.07 M	USA
Zomedica Corp. ZOM	-17.6 M	-	-0.21 %	$ 98 M	USA
Aurora Cannabis ACB	16 M	$ 4.46	13.78 %	$ 245 M	Canada
Bausch Health Companies BHC	1.4 B	$ 5.89	1.55 %	$ 2.18 B	Canada
Canopy Growth Corporation CGC	-63.8 M	$ 0.88	1.04 %	$ 262 M	Canada
China Pharma Holdings CPHI	148 K	$ 0.65	1.57 %	$ 2.79 M	China
Cumberland Pharmaceuticals CPIX	4.93 M	$ 7.09	0.27 %	$ 105 M	USA
Cronos Group CRON	25.9 M	$ 3.25	0.78 %	$ 1.25 B	Canada
Emergent BioSolutions EBS	171 M	$ 7.24	14.29 %	$ 387 M	USA
Evolus EOLS	-42.3 M	$ 7.47	4.62 %	$ 482 M	USA